HOME > BUSINESS
BUSINESS
- Takeda Submits Niraparib for Ovarian Cancer in Japan
December 2, 2019
- Stakeholders Rap Big 4 Wholesalers for Bid-Rigging Charges, Say Scandal Shutters Trust in Drug Price Surveys
November 29, 2019
- 10-Plus Japan Drug Makers Up FY2019 Guidance on Bullish New Drugs, Mainstays: Tally
November 29, 2019
- Rick Kozloski Tapped as President of Alcon Japan
November 29, 2019
- Hisamitsu, Kyowa Kirin Put Off Launch of Haruropi Tape due to Faulty Barcode
November 29, 2019
- Big 4 Drug Wholesalers Raided on Bid-Rigging Charges
November 28, 2019
- Ono Files Tirabrutinib for Add’l Indications in Japan
November 28, 2019
- Ono Seeks to Add 4-Week Dosing to Opdivo Monotherapy
November 28, 2019
- Chugai to End Joint Venture with South Korea's JW Pharma
November 28, 2019
- Chugai Launches Tecentriq 840 mg for Triple-Negative Breast Cancer
November 28, 2019
- ASKA’s Oral Hysteromyoma Drug Shows Non-Inferiority to Leuprorelin in PIII
November 28, 2019
- Sumitomo Dainippon to Launch Global Data Design Office, Leveraging Roivant’s Technology
November 28, 2019
- Otsuka Completes Construction of New Plant in Tokushima
November 28, 2019
- Japan’s First Biosimilars for Nesp, Forteo Hit Shelves
November 27, 2019
- Hisamitsu’s Osteoarthritis Patch Drug Delivers Positive PII Data; PIII Launch Planned in FY2020
November 27, 2019
- Astellas Pharma Grabs China Approval for Xtandi
November 27, 2019
- Kyowa Kirin, Ardelyx Bolster Partnership with Additional Research Deal, US$20 Million Equity Investment
November 27, 2019
- Asahi Kasei to Buy Veloxis for 143.2 Billion Yen, Eyes US Transplant Market
November 26, 2019
- Takeda Set to Pursue 4-Way Global Development, Hails China’s Market Potential
November 26, 2019
- No Need for Acquisitions over Next 5 Years, 12 NMEs to Counter Patent Cliff: Takeda CEO
November 26, 2019
ページ
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
